Therapeutic hypothermia – physiology and evidence
Dr Sanjay Wazir Consultant Neonatology Cloudnine hospital Gurgaon
Therapeutic hypothermia physiology and evidence Dr Sanjay Wazir - - PowerPoint PPT Presentation
Therapeutic hypothermia physiology and evidence Dr Sanjay Wazir Consultant Neonatology Cloudnine hospital Gurgaon Objectives hypothermia treatment Why hypothermia Does it work especially the low cost options How to do it
Dr Sanjay Wazir Consultant Neonatology Cloudnine hospital Gurgaon
Why hypothermia Does it work especially the low cost options How to do it Which babies to be put into treatment
So not all babies who did not cry at birth need treatment
Multiple interventions have been tried but most have not shown benefit
Hypothermia has a sustained benefit
NICHD trial- 33.4 ± 0.4 °C TOBY trial – 33.5 ± 0.5 °C ICE trial – 33.8 ± 0.4 °C
This is the basis why most trails have stuck to this range
Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Nicola J. Robertson, Giles S. Kendall, Sudhin Thayyil
Induction
Maintenance 33-34 C Prevent fluctuations- servo better Avoid cold injury to skin Prevent displacement
Nursing Monitoring
Re-warming Slow 0.2-0.5 C/hr NO rapid rewarming
Adult studies-poor
? Hypotension due to vasodilatation or hyperkalema/hypoglycem ia Rebound seizures reported Not reported in RCT’s
Monitor few hours after normothermia to prevent rebound hyperthermia
Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Nicola J. Robertson, Giles S. Kendall, Sudhin Thayyil
Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Nicola J. Robertson, Giles S. Kendall, Sudhin Thayyil
Passive cooling Cool gel/Ice packs Fans Water bottles Phase-changing material
used if temp not coming down
cooling at all.
with ice packs over a total of 9.6 ± 7.5 hours
Daetwyler K et al. Feasibility and safety of passive cooling in a cohort of asphyxiated newborn infants. Swiss Med Wkly. 2013;143:w13767
Induction achieved -mea±n 52 mins), stable maintenance 33.01±0.4 and smooth re-warming (0.48±0.07C)
Record q15 mins for 1st 4 hour, then q1h
Should have ECG leads, invasive BP-art line/UA, Central access (UV) as far as possible, SPO2 monitoring, Urinary cath/bag Record hourly Change position and check skin for cold injury q4h
A.GA > 35 Wks /Birth Weight > 1800 Gms /<6 Hrs of age
1.ABG (UC/1st postnatal hr) PH<7 or ABE > -12
3.Ventilation required for at Least 10 min
Seizure or Evidence of Moderate and Severe encephalopathy (3 of 6 criteria in modified Criteria)
MODIFIED SARNAT’S STAGING Shankaran et
trial NEJM 2005
OUTBORN
1.GA > 35 wks / Birth Weight > 1800 g/ < 6 hrs of age
Birth/ Required resuscitation/APGAR score < 5 at 5 min(if avail.)
The newborn should fulfill criteria 1, 2,and 3.If not ,do not use the product
Department of Neonatology , Christian Medical College, Vellore, India
> 6 hours of age Major congenital abnormalities, Imperforate anus significant head trauma or skull fracture Coagulopathy with active bleeding Severe PPHN/ possible need for NO Infants < 1,800g-birth weight
Persistent hypoxemia in 100 % oxygen Life threatening coagulopathy Arrthymia requiring medical treatment (not sinus bradycardia) Decision on withdrawal of care-signs of irreversible brain damage
Heart rate Q 1hrly Respiratory Rate Q 1hrly Blood pressure Q 1hrly Spo2 Q 1hrly –more frequent if hypotensive Rectal Temperature Q 1hrly Skin Temp Q 1hrly Neurological examination At recruitment prior to cooling and q 24 hrly till normal and discharge(Thompson scoring) Urine Output Q 6hrly Skin Beakdown/redness Q 4 hrly
Baseline 24 hrs 48 hrs 72 hrs
Y Y Blood urea Y Y
Y Y Blood sugar PT/APTT Y Y Y Y Hb, TLC, DLC,Plt. Y Y Y SGOT/SGPT Y ECG When Clinically Indicated HR < 80/min
Neurological assessment at least once a day till rewarming- eg Sarnat/Thompson Formal eg Amiel-Tison/Hammersmith NNE/TIMP (test for infant motor performance) at 1 week or discharge aEEG Neuroimaging -Ultra sound/MRI with MRS
Sclerema and Subcutaneous fat necrosis Skin erythema Pulmonary hemorrhage Renal failure Increased blood viscosity- hemoconcentration, hyperviscosity DIC Hypoglycemia Acid-base and electrolyte disturbances Increased risk of infections Hypotension- marked decrease in myocardial contractility and cardiac output in experimental animal models Sudden cardiac arrest, VT,VF Pulmonary vasoconstriction.
Asphyxia - huge burden but now interventions for reduction available Selection of babies is key to optimum outcome Servo controlled devices are good but expensive Low cost models are available – look very promising but would need long term data